# Segami Corporation

- Location (FDA's records): Columbia, MD
- FDA decisions: 6 (1997–2007): 6 510(k) clearances
- Names in FDA's records: Segami Corporation (4); Segami Corp., Inc. (2)
- Product codes: LLZ (5), KPS (1)
- Predicates its devices cite: 2 (0 its own); citations of its devices by later devices: 14 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Siemens Gammasonics, Inc.: 1 (https://510kreport.com/company/siemens-gammasonics)
- Sopha Medical Systems, Inc.: 1 (https://510kreport.com/company/sopha-medical-systems)

## Firms that cite its devices most
- Siemens Medical Solutions USA, Inc.: 3 (https://510kreport.com/company/siemens-medical-solutions-usa)
- Syntermed, Inc.: 2 (https://510kreport.com/company/syntermed)
- Cardiarc, Ltd.: 2 (https://510kreport.com/company/cardiarc)
- Siemens Molecular Imaging, Ltd.: 1 (https://510kreport.com/company/siemens-molecular-imaging)
- Gamma Medica-Ideas Incorporated: 1 (https://510kreport.com/company/gamma-medica-ideas)
- Agfa Healthcare N.V.: 1 (https://510kreport.com/company/agfa-healthcare)
- Mimvista Corp.: 1 (https://510kreport.com/company/mimvista)
- Ultraspect, Ltd.: 1 (https://510kreport.com/company/ultraspect)

## Its most-cited devices
- K043441: Mirage, Release 5.5 (2005), cited by 4
- K010726: Modification to Mirage (2001), cited by 4
- K972886: Mirage (1997), cited by 4
- K070397: Dgscope, Release 1.0 (2007), cited by 1
- K071584: Oasis Release 1.0 (2007), cited by 1

## Recent decisions
- K071584: Oasis Release 1.0 (Aug 31, 2007)
- K070397: Dgscope, Release 1.0 (Apr 13, 2007)
- K070683: Mirage Cedars Option (Apr 12, 2007)
- K043441: Mirage, Release 5.5 (Jan 13, 2005)
- K010726: Modification to Mirage (Apr 26, 2001)
- K972886: Mirage (Oct 1, 1997)

Source page: https://510kreport.com/company/segami